Blog
Restez au courant des dernières nouvelles d'Instem.
Application Areas
Clinical Stage
Produit
What inspectors are really looking for
Inspectors expect proof, not promises. Stay inspection ready with continuous monitoring.
The Gaps Between Your Validated Systems
Why compliant systems still leave compliance blind spots, and what to do about them.
Why Scientific Organizations Are Re-Evaluating Oracle-Based Research Platforms
Modernizing infrastructure without disrupting scientific workflows
Why Applicability Domain Matters in (Quantitative) Structure-Activity Relationship (Q)SAR Models: Supporting Interpretation in Mutagenicity Assessments
Understand how applicability domain affects QSAR prediction confidence and why chemical coverage matters when assessing pharmaceutical impurities under ICH M7.
Inspection Week Shouldn’t Feel Like A Fire Drill
Regulatory inspections shouldn’t require weeks of searching for records, rebuilding audit trails, and pulling teams away from their day-to-day work. This blog explores why organisations are moving from reactive inspection preparation to continuous compliance, and...
Beyond the PPD Label: Clearer Language for Stronger Clinical Trial Transparency Submissions
In this blog, we discuss PPD, what different agencies actually care about, and how to navigate CTT language in an ever-changing regulatory landscape.
What’s New in eQCM 10.0.1?
With the release of eQCM 10.0.1, Instem is introducing tighter document control and audit trail integrity for regulated environments.
Introducing Blur™ 2.10: Faster, More Precise Clinical Trial De-Identification
With the release of Blur™ 2.10, Instem is introducing a broad set of enhancements across CSR anonymization, data de-identification, risk simulation, administration, performance, and security.
